Pardi, Norbert
Secreto, Anthony J.
Shan, Xiaochuan
Debonera, Fotini
Glover, Joshua
Yi, Yanjie
Muramatsu, Hiromi
Ni, Houping
Mui, Barbara L.
Tam, Ying K.
Shaheen, Farida
Collman, Ronald G.
Karikó, Katalin
Danet-Desnoyers, Gwenn A.
Madden, Thomas D.
Hope, Michael J.
Weissman, Drew
Article History
Received: 27 April 2016
Accepted: 13 January 2017
First Online: 2 March 2017
Competing interests
: Katalin Karikó and Drew Weissman are named on patents that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins. The remaining authors declare no competing financial interests.